Medical and Pharmaceutical Guardant gets FDA nod for next-gen cancer mutation blood test Milestone builds on firm attaining FDA Breakthrough Device Designation for another liquid biopsy in 2025 Rowan Dunne2 days ago
Medical and Pharmaceutical Guardant Health and Zydus to launch ‘Shield’ multi-cancer test in India The development complements a collaboration the companies initiated in 2023 Rowan DunneMay 6, 2026